C4 Therapeutics Inc
(NASDAQ:CCCC)
$1.0989
-0.3811[-25.75%]
Last update: 3:13PM (Delayed 15-Minutes)
Get Real Time Here
$1.48
0.3811[34.68%]
After-Hours
Open1.470Close-
Vol / Avg.3.382M / 477.770KMkt Cap54.155M
Day Range1.150 - 1.56052 Wk Range1.230 - 9.410

C4 Therapeutics Stock (NASDAQ:CCCC) Earnings Dates and Earning Calls

C4 Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 1

EPS

$-0.550

Quarterly Revenue

$11.1M

Annual Revenue (as of Sep 30)

$20.3M

Earnings History

Analyze the earnings history of C4 Therapeutics using advanced sorting and filters.

Date
▲▼
time
▲▼
ticker
▲▼
Quarter
▲▼
Prior EPS
▲▼
Est EPS
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Prior Rev
▲▼
Est Rev
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Get Alert
02/22/2024AMCCCCQ4-$0.76———$2.85M———Get Alert
11/01/2023AMCCCCQ3-$0.65-$0.66-$0.5516.67%$6.75M$5.46M$11.07M102.78%Get Alert
08/08/2023AMCCCCQ2-$0.56-$0.69-$0.73-5.80%$13.83M$6.44M$2.66M-58.63%Get Alert
05/04/2023AMCCCCQ1-$0.65-$0.75-$0.715.33%$7.65M$5.46M$3.76M-31.15%Get Alert
02/23/2023AMCCCCQ4-$0.31-$0.74-$0.76-2.70%$20.09M$7.81M$2.85M-63.46%Get Alert
11/03/2022AMCCCCQ3-$0.51-$0.67-$0.652.99%$8.50M$9.07M$6.75M-25.53%Get Alert
08/04/2022AMCCCCQ2-$0.51-$0.69-$0.5618.84%$9.78M$7.64M$13.83M81.07%Get Alert
05/05/2022AMCCCCQ1-$0.49-$0.58-$0.65-12.07%$7.43M$8.05M$7.65M-4.92%Get Alert
02/24/2022AMCCCCQ4-$3.45-$0.58-$0.3146.55%$8.26M$7.08M$20.09M183.80%Get Alert
11/10/2021PMCCCCQ3-$17.55-$0.59-$0.5113.56%$8.45M$7.61M$8.50M11.70%Get Alert
08/11/2021PMCCCCQ2—-$0.59-$0.5113.56%—$6.02M$9.78M62.48%Get Alert
05/13/2021PMCCCCQ1—-$0.69-$0.4928.99%$6.80M—$7.43M—Get Alert
03/11/2021PMCCCCQ4——-$3.45———$8.26M—Get Alert
11/12/2020PMCCCCQ3-$8.93—-$17.55—$5.36M—$8.45M—Get Alert
Q

When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?

A

C4 Therapeutics (CCCC) is scheduled to report earnings on February 22, 2024. The last reported earnings were for reported on November 1, 2023 for Q3.

Q

What were the latest earnings per share (EPS) for C4 Therapeutics (NASDAQ:CCCC)?

A

The Actual EPS was $-0.55, which beat the estimate of $-0.66.

Q

What were C4 Therapeutics’s (NASDAQ:CCCC) revenues?

A

The Actual Revenue was $11.1M, which beat the estimate of $5.5M.

Browse earnings estimates, EPS, and revenue on all stocks.